With annual deaths from malaria on the rise: Scientists ask 'where is all the money going?'April 14, 2008New study questions use of millions of dollars dedicated to malaria prevention A new study in the April issue of the American Journal of Tropical Medicine and Hygiene, asks the question "With more than $220 million dollars dedicated to malaria treatment and prevention, why is the annual mortality rate from malaria on the rise" The study, entitled "Malaria Vector Management: Where Have We Come From and Where Are we Headed"" conducted by researchers from the University of Alabama at Birmingham School of Medicine, examines the current methods used to control and prevent the spread of malaria. Robert J. Novak, Ph.D., professor of medicine, division of infectious diseases and Ephantus J. Muturi, Ph.D., postdoctoral fellow, division of infectious diseases, who lead the study, say the millions of dollars currently being spent on malaria primarily address the mortality of pregnant women and infants. And, while these efforts are important and have resulted in successfully decreasing the death rate in that group with the use of bed nets and insecticides, the disease has burgeoned among teens and adults who are not being protected. Dr. Muturi, a native of Kenya, who himself has been stricken by malaria, finds the lack of immediate attention frustrating on a more personal level. "I have family in Kenya who are at risk every day. Bed nets work at night and have helped contain the spread of malaria, but what about the hours when people aren't in their beds" The protection during the day is minimal with current insecticides that cannot be used on a regular basis. The search for a vaccine is necessary, but so are the immediate needs of at-risk communities." The scientists say that organizations such as the Bill & Melinda Gates Foundation and The World Health Organization's Roll Back Malaria, lead in funding research for drug and vaccine development and to provide bed nets, but little of this funding is directed to help identify and address environmental factors that contribute to the growth and spread of this fatal disease. "We need to address three issues - vectors, parasites, and protect the human host, in an integrated fashion" says Dr. Novak. He explains that by working with environmental and epidemiological information that is already available, researchers can determine where malaria mosquito populations are most concentrated and then design a control program with the right preventive methods. "We can quickly access information by working with the Integrated Malaria Management Consortium. But, funding is needed to know where, when and how to apply the current tools that we have to be most effective with disease prevention. And, to properly educate the at-risk populations so they can better protect themselves." Some of the tools that Dr. Novak refers to include modifying the environmental sources proven to house malaria mosquitoes; using environmentally friendly insecticides; determining the exact sections of marsh land, rivers and rice paddies that contain mosquito larvae, and only treating those areas during breeding times to more effectively manage the mosquito population. Identifying these "hot spots" is not only more environmentally friendly, but is also cost effective. "Relying on drugs and bed nets is the same mentality as in the 1960s and we know that thinking didn't work since malaria is still here stronger than ever, so we need to attack the disease in new and more efficient methods," says Dr. Novak. "By properly combining past successful tactics in managing malaria with new technology in insecticides, surveillance, GIS/remote satellite, PCR and new drugs, malaria can become a minor disease." American Society of Tropical Medicine and Hygiene |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||